» Articles » PMID: 33290101

Radiologically Isolated Syndrome: Targeting MiRNAs As Prognostic Biomarkers

Overview
Journal Epigenomics
Specialty Genetics
Date 2020 Dec 8
PMID 33290101
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Some clinical and biological characteristics have been described as prognostic factors for clinical conversion into clinically definite multiple sclerosis in radiologically isolated syndrome (RIS) population. The aim of this study was to assess signatures of circulating miRNAs in those patients according to their conversion status after 5 years of follow-up. OpenArray plates assessing 216 miRNA candidates were run in 15 RIS patients, and their relative abundances were analyzed. A specific profile of deregulated circulating miRNAs (miR-144-3p, miR-448 and miR-653-3p in cerebrospinal fluid and miR-142-3p, miR-338-3p, miR-363-3p, miR-374b-5p, miR-424-5p, miR-483-3p in plasma) differentiated individuals who remained as RIS after 5 years of follow-up. Circulating miRNAs might be used as prognostic biomarkers for RIS patients.

Citing Articles

Early Disease-Modifying Treatments for Presymptomatic Multiple Sclerosis.

Zeydan B, Azevedo C, Makhani N, Cohen M, Tutuncu M, Thouvenot E CNS Drugs. 2024; 38(12):973-983.

PMID: 39285136 PMC: 11560559. DOI: 10.1007/s40263-024-01117-9.


A Literature Review and Meta-Analysis on the Potential Use of miR-150 as a Novel Biomarker in the Detection and Progression of Multiple Sclerosis.

Arcas V, Fratila A, Moga D, Roman-Filip I, Arcas A, Roman-Filip C J Pers Med. 2024; 14(8).

PMID: 39202006 PMC: 11355600. DOI: 10.3390/jpm14080815.


How Early Is Early Multiple Sclerosis?.

Stavropoulou De Lorenzo S, Bakirtzis C, Konstantinidou N, Kesidou E, Parissis D, Evangelopoulos M J Clin Med. 2024; 13(1).

PMID: 38202221 PMC: 10780129. DOI: 10.3390/jcm13010214.


Early to sustained impacts of lethal radiation on circulating miRNAs in a minipig model.

Chakraborty N, Holmes-Hampton G, Gautam A, Kumar R, Hritzo B, Legesse B Sci Rep. 2023; 13(1):18496.

PMID: 37898651 PMC: 10613244. DOI: 10.1038/s41598-023-45250-9.


Cerebrospinal fluid camk2a levels at baseline predict long-term progression in multiple sclerosis.

Sohaei D, Thebault S, Avery L, Batruch I, Lam B, Xu W Clin Proteomics. 2023; 20(1):33.

PMID: 37644477 PMC: 10466840. DOI: 10.1186/s12014-023-09418-9.